Its true incidence is largely unknown, since it is usually estimated in comparison to that of (BCR-ABL1-positive) CML at about one to two cases per 100 cases of CML (2). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.